Anxiety disorders affect up to 25% of all birthing people and are the most common perinatal diagnosis. Diagnosis can be difficult, as some anxiety is normal and adaptive during pregnancy and the postpartum period, and many anxiety symptoms overlap with those of a normal pregnancy. However, treatment is essential to improve birth outcomes, parent-infant bonding, and breastfeeding. Fortunately, most patients respond well to non-pharmacological options, such as cognitive behavioral therapy. This webinar will focus on those who need medication for symptom remission, and will provide an overview of drug classes and their benefits, risks, and dosing strategies.

For more information on Perinatal Resource to Optimize Mental Health Interventions and Substance Use Treatment Excellence (PROMISE) please view their website.